Brandon Cain, MD
Vascular Surgery · Greensboro, NCNPI 1730407040
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,105 of the $7,428 with a category attached, or 82.2%. 24 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 28.8% of the total. Reporting peaked in 2019 at $3,132 and has fallen 86.2% since, to $432 in 2025.
Across 230 payments — averaging $32.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$2K
- Boston Scientific$2K
- Silk Road Medical, Inc.$864
- Inari Medical, Inc.$514
- Medtronic$433
- Cook Medical LLC$395
- plus $1K from 18 others
What the payments were for
- Travel & lodging$1,27817%
- Food & beverage$6,10582%
- Education$461%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 77 | $2,137 |
| Boston Scientific | 56 | $1,713 |
| Silk Road Medical, Inc. | 14 | $864 |
| Inari Medical, Inc. | 19 | $514 |
| Medtronic(2 entities) | 5 | $433 |
| Cook Medical LLC | 15 | $395 |
| Angiodynamics, Inc. | 6 | $275 |
| Stryker | 4 | $230 |
| Cardiovascular Systems Inc. | 5 | $189 |
| Endologix LLC | 2 | $148 |
| Amgen | 7 | $123 |
| Chiesi USA, Inc. | 1 | $78 |
| Abbott | 3 | $64 |
| Johnson & Johnson | 2 | $62 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $49 |
| Lemaitre Vascular, Inc. | 2 | $36 |
| Edwards Lifesciences | 1 | $28 |
| Teleflex LLC | 1 | $14 |
| Covidien LP | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Aroa Biosurgery Incorporated | 1 | $13 |
| Novartis | 1 | $13 |
| Terumo Medical Corporation | 1 | $12 |
| Surmodics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$623
- ENROUTE Transcarotid Stent System$623
- ENHANCE Transcarotid Peripheral Access Kit$623
- ENROUTE 0.014 Guidewire$623
- GENERAL - THERAPIES$606
- ENDURANT IIS$360
- C3 Delivery System$310
- GORE TAG Conformable Thoracic Endoprosthesis$168
- CLOTTRIEVER BOLD CATHETER$164
- Conformable TAG Thoracic Endoprosthesis$150
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$138
- Diamondback Peripheral$124
- Cook Medical AAA$124
- VenaCure 1470 Pro$116
- GORE VIABAHN VBX Balloon Expandable Endo$116
How this compares
$7,428 in reported general payments places this provider in the 70th percentile of 119 vascular surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 86 | $61,131 |
| XareltoRivaroxaban | 27 | $21,507 |
| ClopidogrelClopidogrel Bisulfate | 425 | $5,016 |
| Rosuvastatin Calcium | 85 | $793 |
| Atorvastatin Calcium | 34 | $668 |
| Cilostazol | 49 | $606 |
| Lorazepam | 11 | $6 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $62 | $21,50727 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 119 vascular surgery providers in North Carolina.
Other vascular surgery in Greensboro
- Brian ChenGreensboro$22K
- Vance BrabhamGreensboro$16K
- Tyler BuckleyGreensboro$14K
- Thomas HawkenGreensboro$5K
- Christopher ClarkGreensboro$3K
- Frank ArkoCharlotte$2.6M
- Erin MurphyCharlotte$598K
- Robert MendesRaleigh$408K
- Ellen DillavouRaleigh$284K
- Mark FarberChapel Hill$245K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.